[1] KOLASINSKI SL, NEOGI T, HOCHBERG MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72(2): 220-233.
[2] MOTTA F, BARONE E, SICA A, et al. Inflammaging and Osteoarthritis. Clin Rev Allergy Immunol. 2023;64(2):222-238.
[3] YUNUS MHM, NORDIN A, KAMAL H. Pathophysiological Perspective of Osteoarthritis. Medicina (Kaunas). 2020;56(11):614.
[4] WEN C, XIAO G. Advances in osteoarthritis research in 2021 and beyond. J Orthop Translat. 2022;32:A1-A2.
[5] LONG H, LIU Q, YIN H, et al. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022; 74(7):1172-1183.
[6] MINNIG MCC, GOLIGHTLY YM, NELSON AE. Epidemiology of osteoarthritis: literature update 2022-2023. Curr Opin Rheumatol. 2024;36(2):108-112.
[7] 王新力. α-酮戊二酸纳米复合缓释药物的制备及其在治疗骨性关节炎中的作用研究[D]. 西安:中国人民解放军空军军医大学,2025.
[8] SITTER T, FORGET P. Persistent postoperative opioid use in Europe: A systematic review. Eur J Anaesthesiol. 2021;38(5):505-511.
[9] HUSSAIN SM, NEILLY DW, BALIGA S, et al. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7-16.
[10] ZHOU G, ZHANG X, GU Z, et al. Research progress on the treatment of knee osteoarthritis combined with osteoporosis by single-herb Chinese medicine and compound. Front Med (Lausanne). 2023;10:1254086.
[11] 秦翠英, 郭祖昌, 张杰, 等. 药食同源物质在主动健康和人口老龄化科技应对方面的应用展望[J]. 中国实验方剂学杂志,2025, 31(15):258-267.
[12] HU X, ZENG Z, ZHANG J, et al. Molecular dynamics simulation of the interaction of food proteins with small molecules. Food Chem. 2023;405(Pt A):134824.
[13] CHEN W, YANG Q, HU L, et al. Shared diagnostic genes and potential mechanism between PCOS and recurrent implantation failure revealed by integrated transcriptomic analysis and machine learning. Front Immunol. 2023;14:1175384.
[14] BOWDEN J, DEL GRECO MF, MINELLI C, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48(3):728-742.
[15] BOWDEN J, DAVEY SMITH G, BURGESS S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525.
[16] Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508-e522.
[17] 郭素蓉, 曹士盛, 穆星彤, 等. Compound 3k治疗骨关节炎:调控氧化应激通路改善软骨细胞糖酵解的作用机制[J]. 中国组织工程研究,2025,29(2):363-370.
[18] QIAO S, ZHAO R, HE S, et al. Quercitrin attenuates the progression of osteoarthritis via inhibiting NF-kappaB signaling pathways and enhance glucose transport capacity. Exp Cell Res. 2023;433(2):113854.
[19] TROMPETER N, GARDINIER JD, DEBARROS V, et al. Insulin-like growth factor-1 regulates the mechanosensitivity of chondrocytes by modulating TRPV4. Cell Calcium. 2021;99:102467.
[20] 冯天阳, 邓乐, 徐构, 等. ESCRT机制介导的调节性细胞死亡引起的质膜损伤修复及其机制(英文)[J]. 生物化学与生物物理进展, 2025,52(5):1099-1112.
[21] CHEN R, YING C, ZOU Y, et al. Sarsasapogenin inhibits YAP1-dependent chondrocyte ferroptosis to alleviate osteoarthritis. Biomed Pharmacother. 2023;168:115772.
[22] 李豪, 陶红成, 曾平, 等. 丝裂原活化蛋白激酶信号通路调控骨关节炎的发生发展:指导中药靶点治疗[J]. 中国组织工程研究, 2026,30(6):1476-1485.
[23] DEL SORDO L, BLACKLER GB, PHILPOTT HT, et al. Impaired Efferocytosis by Synovial Macrophages in Patients With Knee Osteoarthritis. Arthritis Rheumatol. 2023;75(5):685-696.
[24] TANG Y, HU X, LU X. Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system. Int J Clin Exp Med. 2015;8(8):12584-12592.
[25] WEN J, LYU P, STOLZER I, et al. Epithelial HIF2alpha expression induces intestinal barrier dysfunction and exacerbation of arthritis. Ann Rheum Dis. 2022;81(8):1119-1130.
[26] HAO X, ZHANG J, SHANG X, et al. Exercise modifies the disease-relevant gut microbial shifts in post-traumatic osteoarthritis rats. Bone Joint Res. 2022;11(4):214-225.
[27] NAOT D, WATSON M, CHOI AJ, et al. The effect of age on the microarchitecture and profile of gene expression in femoral head and neck bone from patients with osteoarthritis. Bone Rep. 2020;13:100287.
[28] RUFINO AT, ROSA SC, JUDAS F, et al. Expression and function of K(ATP) channels in normal and osteoarthritic human chondrocytes: possible role in glucose sensing. J Cell Biochem. 2013; 114(8):1879-1889.
[29] XIANG J, CHEN H, LIN Z, et al. Identification and experimental validation of ferroptosis-related gene SLC2A3 is involved in rheumatoid arthritis. Eur J Pharmacol. 2023;943:175568.
[30] YAO X, LI W, FANG D, et al. Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. Adv Sci (Weinh). 2021;8(22):e2100997.
[31] JIANG D, GUO J, LIU Y, et al. Glycolysis: an emerging regulator of osteoarthritis. Front Immunol. 2023;14:1327852.
[32] 李宏元, 杨柳, 靳宪辉. 缺氧诱导因子与骨稳态失衡类疾病的相关性[J]. 中国组织工程研究,2022,26(33):5393-5399.
[33] 苏永昆, 孙红, 杨华, 等. 缺氧诱导因子在骨关节炎中的研究进展[J]. 中国矫形外科杂志,2025,33(21):1947-1951.
[34] YAO X, HE Z, QIN C, et al. SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int. 2020;20:503.
[35] YANG P, TAN J, YUAN Z, et al. Expression profile of cytokines and chemokines in osteoarthritis patients: Proinflammatory roles for CXCL8 and CXCL11 to chondrocytes. Int Immunopharmacol. 2016;40:16-23.
[36] CAMBIER S, GOUWY M, PROOST P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023;20(3):217-251.
[37] SAMUS M, ROT A. Atypical chemokine receptors in cancer. Cytokine. 2024;176:156504.
[38] ZHU Y, DENG L, XIA J, et al. Identification of Key Glycolysis-Related Genes in Osteoarthritis and Their Correlation with Immune Infiltration Using Bioinformatics Analysis and Machine Learning. Open Access Rheumatol. 2025;17:157-171.
[39] COMERFORD I, MCCOLL SR. Atypical chemokine receptors in the immune system. Nat Rev Immunol. 2024;24(10):753-769.
[40] KULKARNI P, HARSULKAR A, MARTSON A, et al. Mast Cells Differentiated in Synovial Fluid and Resident in Osteophytes Exalt the Inflammatory Pathology of Osteoarthritis. Int J Mol Sci. 2022; 23(1).DOI:10.3390/ijms23010541.
[41] LEI Y, GUO X, LUO Y, et al. Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis. Nat Commun. 2024;15(1):113.
[42] MIHLAN M, WISSMANN S, GAVRILOV A, et al. Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay. Cell. 2024;187(19):5316-5335.
[43] 李虎业, 窦增花, 孔德元, 等. 山茱萸新苷Ⅰ干预膝骨关节炎模型大鼠抑制白细胞介素6介导的炎性反应[J]. 中国组织工程研究, 2021,25(2):211-215.
[44] YU H, YAO S, ZHOU C, et al. Morroniside attenuates apoptosis and pyroptosis of chondrocytes and ameliorates osteoarthritic development by inhibiting NF-kappaB signaling. J Ethnopharmacol. 2021;266:113447.
[45] LIU Y, ZHOU C, TAN J, et al. Ganoderic acid A slows osteoarthritis progression by attenuating endoplasmic reticulum stress and blocking NF-Kappab pathway. Chem Biol Drug Des. 2024; 103(1):e14382.
[46] 李博. 天麻素调节自噬对骨关节炎软骨细胞的保护作用和机制研究[D]. 上海:中国人民解放军海军军医大学,2023.
[47] WU Z, WANG Y, YAN G, et al. Eugenol protects chondrocytes and articular cartilage by downregulating the JAK3/STAT4 signaling pathway. J Orthop Res. 2023;41(4):747-758.
[48] BAKRIM S, BENKHAIRA N, BOURAIS I, et al. Health Benefits and Pharmacological Properties of Stigmasterol. Antioxidants (Basel). 2022;11(10).DOI:10.3390/antiox11101912.
[49] MO Z, XU P, LI H. Stigmasterol alleviates interleukin-1beta-induced chondrocyte injury by down-regulatingsterol regulatory element binding transcription factor 2 to regulateferroptosis. Bioengineered. 2021; 12(2):9332-9340.
[50] LIM JH, KIM SE, KIM H, et al. Intra-articular injection of stigmasterol-loaded nanoparticles reduce pain and inhibit the inflammation and joint destruction in osteoarthritis rat model: A pilot study. Drug Deliv Transl Res. 2024; 14(7):1969-1981.
|